More about
Advanced Classical Hodgkin Lymphoma
News
June 22, 2023
7 min watch
Save
VIDEO: 'Potentially practice-changing' results from SWOG S1826 trial a highlight of ASCO
In this video, Joshua Brody, MD, discussed the results of the SWOG S1826 trial of nivolumab vs. brentuximab vedotin in advanced-stage classic Hodgkin lymphoma, which were presented at ASCO Annual Meeting.